Search for Clinical Trial Results
Lipid Metabolism, Inborn Errors - 25 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Sitosterolemia Metabolism Condition: Sitosterolemia Date: 2012-04-16 Interventions: Drug: Ezetimibe 10mg ezetimibe/day, at least 4 months |
Completed |
Study Name: An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia Condition:
|
Completed |
Study Name: Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia Condition:
|
Completed |
Study Name: Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia Condition:
|
Completed |
Study Name: Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration Condition:
Interventions: |
Recruiting |
Study Name: Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy Condition:
Date: 2015-12-09 Interventions: Other: Sugar 10 minutes before exercising, the subjects are given a bolus of glucose solution 0.2 g/kg i |
Completed |
Study Name: Effect of Bezafibrate on Muscle Metabolism in Patients With Fatty Acid Oxidation Defects Condition:
|
Enrolling by invitation |
Study Name: Natural History of Pearson Syndrome Condition: Pearson Syndrome Date: 2014-12-22 |
Terminated |
Study Name: Phase 2 Study of EPI-743 in Children With Pearson Syndrome Condition: Pearson Syndrome Date: 2014-04-02 Interventions: Drug: EPI-743 EPI-743 is the quinone oxidation product of alpha-tocotrienol |
Recruiting |
Study Name: Biomarker for Mucolipidosis Disorder Type I, II, III or IV Condition:
|